Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam. Feugiat mi libero lacus in ac magna turpis viverra.

Subscribe to news

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.

Latest news

International Business Times: AI meets enzymes - eXoZymes enables high-yield production of compounds previously impossible to make

IBT: AI meets enzymes
Read more

Beryl Elites: AI's Billion-dollar Bet on Life Sciences - From Drug Discovery to Patient Impact (panel)

CEO Michael Heltzen at the Beryl Elite's 'AI in Life Sciences' panel
Read more

eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversion

100× scale-up of NCT production achieved
Read more

Vanity Fair: Inside NCTx - How A Rare Plant-Derived Molecule Is Turning Fat Into A Boost Of Energy

Read more